BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16296697)

  • 1. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
    Abernethy DR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine.
    Elliott HL; Meredith PA
    Postgrad Med J; 1991; 67 Suppl 3():S20-3. PubMed ID: 1836870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of amlodipine in the management of ischaemic heart disease.
    McGibney D
    Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetic profile of amlodipine.
    Abernethy DR
    Am Heart J; 1989 Nov; 118(5 Pt 2):1100-3. PubMed ID: 2530866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of brodimoprim in special populations.
    Stockis A; Borzio F; Deroubaix X; Gaspari F; Jeanbaptiste B; Lebacq E; Lins R; Pavesio D; Pelozi GC; Rosillon D
    J Chemother; 1993 Dec; 5(6):480-7. PubMed ID: 8195841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral amlodipine orotate in vagotomized dogs.
    Kwak HH; Kim JO; Chung HK; Choi SM; Kim JH; Kwon JW; Yoo M; Lee JH; Lee MG
    Biopharm Drug Dispos; 2006 Apr; 27(3):141-5. PubMed ID: 16400620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
    Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
    Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
    Stangier J; Su CA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
    Fourtillan JB; Ingrand I; Decourt JP; Istin B; Girault J
    Therapie; 1998; 53(2):121-6. PubMed ID: 9773111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amlodipine; clinical relevance of a unique pharmacokinetic profile.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S6-8. PubMed ID: 7522286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of amlodipine.
    Meredith PA; Elliott HL
    Clin Pharmacokinet; 1992 Jan; 22(1):22-31. PubMed ID: 1532771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties.
    van Zwieten PA
    Clin Cardiol; 1994 Sep; 17(9 Suppl 3):III3-6. PubMed ID: 9156957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dosing interval on the pharmacokinetic interaction between oral small spherical activated charcoal and amlodipine in humans.
    Tanaka C; Ohtani H; Tsujimoto M; Ohdo S; Taniguchi M; Mizooku Y; Saitoh Y; Kimura M; Uchimaru H; Irie S; Sawada Y
    J Clin Pharmacol; 2007 Jul; 47(7):904-8. PubMed ID: 17585118
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].
    Rameis H
    Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of metabolic stability and hepatic distribution to the pharmacokinetic profile of amlodipine.
    Walker DK; Humphrey MJ; Smith DA
    Xenobiotica; 1994 Mar; 24(3):243-50. PubMed ID: 8009887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of amlodipine.
    Abernethy DR
    Cardiology; 1992; 80 Suppl 1():31-6. PubMed ID: 1534713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of amlodipine in hypertensive children and adolescents.
    Flynn JT; Nahata MC; Mahan JD; Portman RJ;
    J Clin Pharmacol; 2006 Aug; 46(8):905-16. PubMed ID: 16855075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.